YOLFTbeta
Neuronetics Inc

Neuronetics Inc

STIM · NASDAQ · Healthcare / Medical Devices

1.39USD-0.04 (-2.80%)

Price History

Full chart

Market Stats

Previous Close1.43
Open1.21
Day Range1.20 – 1.44
52-Week Range0.80 – 3.44
Volume16.24M
Market Cap194.68M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.43
Dividend Yield0.00%
Beta1.17
50-Day Avg2.66
200-Day Avg1.81

About

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Daniel L. Reuvers
  • Employees658
  • Headquarters3222 Phoenixville Pike, Malvern, PA, United States, 19355, USA
  • Websitehttps://neurostar.com/neuronetics

Leadership

  • Mr. Daniel L. ReuversCEO, President & Director · b. 1963
  • Mr. Nir Naor C.F.A., CPA, L.L.M., M.B.A.Executive VP, CFO, Corporate Secretary, Principal Financial and Accounting Officer & Treasurer · b. 1975
  • Mr. Robert GreeneSenior Vice President of Sales
  • Mr. Cory S. AndersonExecutive Vice President & General Manager of Greenbrook · b. 1977

Financials

Income Statement

Currency: USD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue34.23M40.43M52.78M62.66M49.24M55.31M65.21M71.35M74.89M149.16M
Growth (%)-+18.13%+30.53%+18.72%-21.41%+12.32%+17.89%+9.42%+4.96%+99.17%
Cost of Revenue6.62M9.63M12.45M15.39M11.55M11.65M15.48M19.64M20.73M76.85M
Gross Profit27.61M30.80M40.33M47.27M37.69M43.66M49.72M51.70M54.16M72.31M
Gross Margin80.65%76.18%76.42%75.44%76.54%78.93%76.26%72.47%72.32%48.48%
Operating Expense36.94M44.41M60.16M74.20M60.00M71.22M84.83M82.26M88.72M103.74M
Operating Income-9.34M-13.61M-19.83M-26.93M-22.31M-27.56M-35.11M-30.55M-34.56M-31.44M
Operating Margin-27.28%-33.66%-37.58%-42.98%-45.30%-49.83%-53.85%-42.82%-46.15%-21.08%
EBITDA-8.73M-12.58M-19.53M-27.19M-25.89M-26.81M-31.96M-22.76M-34.37M-27.12M
EBITDA Margin-25.49%-31.11%-37.00%-43.40%-52.57%-48.48%-49.01%-31.90%-45.89%-18.18%
Net Income-11.23M-16.06M-24.10M-29.04M-27.45M-31.19M-37.16M-30.19M-43.71M-39.00M
Net Income Margin-32.82%-39.72%-45.66%-46.35%-55.75%-56.39%-56.99%-42.31%-58.36%-26.15%
R&D8.22M7.94M8.23M13.75M9.20M7.92M9.34M9.52M12.77M6.58M
R&D as % of Total Revenue24.02%19.63%15.60%21.94%18.68%14.32%14.32%13.34%17.05%4.41%
Interest Expense1.83M2.81M3.69M3.69M4.52M3.30M3.60M5.42M7.29M8.41M
Interest Expense % of Total Revenue5.36%6.94%6.99%5.88%9.18%5.97%5.52%7.60%9.73%5.64%

Balance Sheet

Currency: USD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets24.80M38.94M117.02M100.17M78.66M141.22M116.88M115.83M140.90M141.55M
Total Liabilities201.92M231.59M45.98M52.32M53.16M56.05M59.82M81.64M109.10M115.31M
Total Equity-177.12M-192.65M71.04M47.85M25.49M85.17M57.06M34.19M27.71M22.38M
Cash17.04M29.15M104.58M75.71M48.96M94.14M70.34M59.68M19.46M34.13M
Total Debt20.60M59.59M30.39M34.33M38.34M39.54M39.74M62.47M82.63M90.30M
Net Debt3.10M409.00K-74.19M-41.38M-10.62M-54.60M-30.59M2.80M63.17M56.17M

Cash Flow

Currency: USD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-8.54M-11.14M-20.59M-30.48M-28.39M-27.98M-30.74M-32.04M-31.00M-20.37M
Investing Cash Flow-324.00K-594.00K-1.01M-813.00K-730.00K-9.84M6.73M-1.32M-2.41M-801.00K
Financing Cash Flow4.90M23.84M97.04M2.42M2.37M83.01M207.00K22.70M-6.81M35.85M
Capital Expenditure324.00K594.00K1.01M813.00K730.00K2.35M3.27M2.37M1.47M801.00K
Free Cash Flow-8.87M-11.74M-21.60M-31.30M-29.12M-30.34M-34.01M-34.41M-32.46M-21.18M
FCF to OCF103.79%105.33%104.91%102.67%102.57%108.41%110.63%107.39%104.73%103.93%

Earnings

Report DateJun 29, 2018Aug 14, 2018Nov 6, 2018Mar 5, 2019May 7, 2019Aug 6, 2019Nov 5, 2019Mar 3, 2020May 5, 2020Aug 4, 2020Nov 2, 2020Mar 2, 2021May 4, 2021Aug 3, 2021Nov 9, 2021Mar 8, 2022May 12, 2022Aug 2, 2022Nov 8, 2022Mar 7, 2023May 9, 2023Aug 8, 2023Nov 7, 2023Mar 5, 2024May 7, 2024Aug 12, 2024Nov 12, 2024Mar 4, 2025May 6, 2025Aug 5, 2025Nov 4, 2025Mar 17, 2026May 5, 2026Aug 11, 2026Nov 3, 2026
EPS Estimate0.00-0.88-0.40-0.37-0.40-0.41-0.43-0.44-0.46-0.50-0.28-0.24-0.31-0.24-0.30-0.32-0.40-0.41-0.42-0.38-0.39-0.35-0.28-0.26-0.31-0.27-0.23-0.24-0.12-0.08-0.12-0.11-0.17-0.11-0.08
EPS Actual0.02-0.67-0.29-0.35-0.42-0.39-0.37-0.41-0.63-0.41-0.18-0.19-0.31-0.29-0.31-0.29-0.41-0.39-0.28-0.30-0.38-0.17-0.33-0.19-0.27-0.33-0.44-0.33-0.21-0.15-0.13-0.10-0.15-0.05-
Surprise-23.86%27.50%5.41%-5.00%4.88%13.95%6.82%-36.96%18.00%35.71%20.83%0.00%-20.83%-3.33%9.38%-2.50%4.88%33.33%21.05%2.56%51.43%-17.86%26.92%12.90%-22.22%-91.30%-37.50%-75.00%-87.50%-8.33%9.09%11.76%54.55%-
TimingAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap194.68M
Enterprise Value288.06M
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.26
Price / Book12.38
EPS-0.43
Book Value0.234
Revenue (TTM)155.10M
Gross Profit (TTM)76.59M
EBITDA-19.26M
Profit Margin-19.62%
Operating Margin-3.61%
Return on Equity-116.10%
Return on Assets-10.55%
Shares Outstanding76.20M
Shares Float37.15M
Beta1.17
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 4 analystsTarget 5.75
  • Strong Buy
    1
  • Buy
    2
  • Hold
    1

Ownership Breakdown

Institutions
54.00%
Insiders
30.88%
Retail / Other
15.12%

Top Institutional Holders

  • Madryn Asset Management, LP
    18.54M24.33%
  • UBS Group AG
    2.87M3.77%
  • Balyasny Asset Management LLC
    2.74M3.60%
  • BlackRock Inc
    2.32M3.04%
  • Vanguard Capital Management, LLC
    2.05M2.69%
  • Wexford Capital LP
    2.00M2.63%
  • FourWorld Capital Management LLC
    1.74M2.29%
  • Lane Generational LLC
    1.63M2.14%
  • Masters Capital Management LLC
    1.00M1.31%
  • Geode Capital Management, LLC
    958.99K1.26%
  • State Street Corp
    842.55K1.11%
  • AdvisorShares Investments, LLC
    742.79K0.97%
  • Ikarian Capital, LLC
    701.18K0.92%
  • HighTower Advisors, LLC
    562.37K0.74%
  • Citadel Advisors Llc
    421.90K0.55%
  • Northern Trust Corp
    277.38K0.36%
  • Dauntless Investment Group, LLC
    269.21K0.35%
  • Vanguard Fiduciary Trust Co
    258.03K0.34%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    1.06M1.39%
  • AdvisorShares Psychedelics ETF
    864.50K1.13%